Treating Depression Found to Up Successful Opioid Cessation

Share this content:
Treating Depression Found to Up Successful Opioid Cessation
Treating Depression Found to Up Successful Opioid Cessation

TUESDAY, Feb. 13, 2018 (HealthDay News) -- Antidepressant medication (ADM) adherence is associated with cessation of long-term prescription opioid use among patients with non-cancer pain, according to a study published in the February issue of the British Journal of Psychiatry.

Jeffrey F. Scherrer, Ph.D., from the Saint Louis University School of Medicine, and colleagues assessed whether adherence to ADM is associated with opioid cessation in 2,821 non-cancer, non-HIV patients with a new depression episode after >90 days of opioid analgesic use. Patients with an ADM prescription filled from 2002 to 2012 were eligible.

The researchers found that the incidence rate of opioid cessation was significantly (P = 0.007) greater in patients who adhered to antidepressants versus those who did not adhere. There was a significant association between ADM adherence and opioid cessation (odds ratio, 1.24).

"Opioid taper and cessation may be more successful when depression is treated to remission," the authors write.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Moves to Restrict Flavored E-Cig Sales, Ban Menthol Cigarettes

FDA Moves to Restrict Flavored E-Cig Sales, Ban ...

The move stops short of the full ban on e-cigarettes that had been expected

Name-Brand Medications Driving Spike in U.S. Drug Spending

Name-Brand Medications Driving Spike in U.S. Drug Spending

Greatest costs for Humira, Remicade, Enbrel, Novolog, and Neulasta

is free, fast, and customized just for you!




Already a member?

Sign In Now »